Back to Agenda
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Session Chair(s)
Julie Guery, PHD
Global Regulatory Affairs Labeling Head
Sanofi, United States
Explore how patient-focused principles can transform product labeling into a strategic asset. Learn how to integrate patient perspectives early, align with regulatory trends, & leverage labeling to support decision-making and differentiate products.
Learning Objective : Identify opportunities to incorporate patient experience data into product labeling that aligns with FDA/EMA guidance; Examine case studies of successful patient-centered labeling that supports decision-making; Outline approaches to develop labeling strategies that bridge regulatory requirements with patient value.
Speaker(s)
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Representative Invited
FDA, United States
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Representative Invited
European Medicines Agency, Netherlands
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Jason Harris
National Psoriasis Foundation, United States
Vice President, Government Relations and Advocacy
Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication
Kelly Treonze, MS
Merck & Co., Inc., United States
Head, Global Labeling
Have an account?